Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 8, Issue 7, Pages -
Publisher
Springer Nature
Online
2018-06-26
DOI
10.1038/s41408-018-0101-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms
- (2018) Malin Hultcrantz et al. ANNALS OF INTERNAL MEDICINE
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Administration of direct oral anticoagulants in patients with myeloproliferative neoplasms
- (2017) Jean-Christophe Ianotto et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation
- (2017) Roberto Castelli et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients
- (2017) S. Cerquozzi et al. Blood Cancer Journal
- Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management
- (2016) Ayalew Tefferi et al. AMERICAN JOURNAL OF HEMATOLOGY
- How I treat essential thrombocythemia
- (2016) E. Rumi et al. BLOOD
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry
- (2016) A. Kaifie et al. Journal of Hematology & Oncology
- High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists
- (2016) V De Stefano et al. LEUKEMIA
- Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial
- (2016) Gary E Raskob et al. Lancet Haematology
- Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia
- (2015) Juan-Carlos Hernández-Boluda et al. ANNALS OF HEMATOLOGY
- Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer
- (2015) Agnes Y. Y. Lee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism
- (2015) Antonio Gómez-Outes et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology
- (2014) T. Barbui et al. BLOOD
- How I treat polycythemia vera
- (2014) A. M. Vannucchi BLOOD
- Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism
- (2014) T. van der Hulle et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Treatment of thromboembolic events coincident with the diagnosis of myeloproliferative neoplasms: A physician survey
- (2014) Martin H. Ellis et al. THROMBOSIS RESEARCH
- Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
- (2013) A Tefferi et al. LEUKEMIA
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: An international study of 264 patients
- (2012) Veronika Buxhofer-Ausch et al. AMERICAN JOURNAL OF HEMATOLOGY
- Venous thromboembolism: Epidemiology and magnitude of the problem
- (2012) Samuel Z. Goldhaber BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Antithrombotic Therapy for VTE Disease
- (2012) Clive Kearon et al. CHEST
- Cerebral sinus-venous thrombosis
- (2012) Ida Martinelli et al. Internal and Emergency Medicine
- Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH
- (2012) T. BAGLIN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis
- (2011) Valerio De Stefano et al. AMERICAN JOURNAL OF HEMATOLOGY
- Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
- (2011) A. Carobbio et al. BLOOD
- Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Heparin-Induced Thrombocytopenia in Patients with Philadelphia-Negative Myeloproliferative Disorders and Unusual Splanchnic or Cerebral Vein Thrombosis
- (2010) Maria L. Randi et al. ACTA HAEMATOLOGICA
- Splanchnic vein thrombosis: clinical presentation, risk factors and treatment
- (2010) Valerio De Stefano et al. Internal and Emergency Medicine
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Thrombosis in primary myelofibrosis: incidence and risk factors
- (2009) T. Barbui et al. BLOOD
- Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia
- (2009) V. De Stefano et al. HAEMATOLOGICA
- Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review
- (2009) Federico Lussana et al. THROMBOSIS RESEARCH
- Heparin-induced thrombocytopenia in myeloproliferative disorders: A rare or under-diagnosed complication?
- (2008) Galia Spectre et al. AMERICAN JOURNAL OF HEMATOLOGY
- Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain
- (2008) P. D. Ziakas HAEMATOLOGICA
- Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
- (2008) V. De Stefano et al. HAEMATOLOGICA
- Is JAK2 V617F mutation more than a diagnostic index?
- (2008) Issa J. Dahabreh et al. LEUKEMIA RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started